Factors Affecting Receipt of Expensive Cancer Treatments and Mortality: Evidence from Stem Cell Transplantation for Leukemia and Lymphoma-Reference-Cited by-同舟云学术

Factors Affecting Receipt of Expensive Cancer Treatments and Mortality: Evidence from Stem Cell Transplantation for Leukemia and Lymphoma

Published:2014-07-22 Issue:1 Volume:50 Page:197-216
ISSN:0017-9124
Container-title:Health Services Research
language:en
Short-container-title:Health Serv Res

Author:

Mitchell Jean M.¹,Conklin Elizabeth A.²

Affiliation:

1. McCourt School of Public Policy; Georgetown University; Washington DC

2. Health Care Analyst; US Government Accountability Office; Seattle WA

Publisher

Wiley

Subject

Health Policy

Reference23 articles.

1. Problems with Instrumental Variables Estimation when the Correlation between the Instruments and the Endogenous Explanatory Variable Is Weak;Bound;Journal of the American Statistical Association,1995

2. Chronic Myelogenous Leukemia;D'Antonio;Clinical Journal of Oncology Nursing,2005

3. Comorbidity Measures for Use with Administrative Data;Elixhauser;Medical Care,1998

4. Choosing among Alternative Nonexperimental Methods for Estimating the Impact of Social Programs: The Case of Manpower Training;Heckman;Journal of the American Statistical Association,1989

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in access to hematopoietic cell transplant persist at a transplant center;Bone Marrow Transplantation;2024-06-13

2. Disparities in Access to Hematopoietic Cell Transplant Persist at a Transplant Center;2024-01-12

3. The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients;Transplantation and Cellular Therapy;2023-10

4. Stem Cell Therapy in Cancer;Targeted Cancer Therapy in Biomedical Engineering;2023

5. Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia;Transplantation and Cellular Therapy;2022-12